Evaluation of the impact of once weekly dulaglutide on patient-reported outcomes in Japanese patients with type 2 diabetes: comparisons with liraglutide, insulin glargine, and placebo in two randomized studies
Crossref DOI link: https://doi.org/10.1186/s12955-017-0696-7
Published Online: 2017-06-12
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Suzuki, Shuichi
Oura, Tomonori
Takeuchi, Masakazu
Boye, Kristina S.
Funding for this research was provided by:
Eli Lilly Japan KK